Literature DB >> 24124271

Reversible chemical restraint of free-range cattle with a concentrated combination of tiletamine-zolazepam, ketamine, and detomidine.

Michela Re1, Francisco J Blanco-Murcia, José Maria San Miguel, Ignacio A Gómez de Segura.   

Abstract

The aim of this study was to determine the efficacy of a concentrated combination of tiletamine-zolazepam [TZ, 0.53 mg/kg body weight (BW)], ketamine (Ket, 0.53 mg/kg BW), and detomidine (Det, 0.04 mg/kg BW) in the immobilization of free-range cattle for clinical procedures. The combination was administered intramuscularly to 53 animals. Anesthesia was reversed with the α2-adrenoceptor antagonist atipamezole. Locoregional anesthesia was provided with lidocaine when required. The TZKD combination induced suitable immobilization for minor surgical procedures or medical treatments. Anesthetic onset was rapid, taking a mean of 6.1 min [standard deviation (SD) 2.8 min]. The duration of anesthesia depended on the time of administration of the antagonist; the animals recovered in the standing position in 12.9 ± 8.9 min after the administration of atipamezole. The quality of anesthesia and analgesia were satisfactory. In conclusion, this TZKD combination can be used for both immobilization and minor surgical procedures in free-range cattle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24124271      PMCID: PMC3788660     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  16 in total

1.  Chemical restraint and anaesthetic effects of a tiletamine-zolazepam/ketamine/detomidine combination in cattle.

Authors:  Michela Re; Francisco J Blanco-Murcia; Ignacio A Gómez de Segura
Journal:  Vet J       Date:  2010-10-29       Impact factor: 2.688

2.  Estimation of body weight from body size measurements and body condition scores in dairy cows.

Authors:  C Enevoldsen; T Kristensen
Journal:  J Dairy Sci       Date:  1997-09       Impact factor: 4.034

3.  Anesthesia of wood bison with medetomidine-zolazepam/tiletamine and xylazine-zolazepam/tiletamine combinations.

Authors:  N A Caulkett; M R Cattet; S Cantwell; N Cool; W Olsen
Journal:  Can Vet J       Date:  2000-01       Impact factor: 1.008

4.  Evaluation of a butorphanol, detomidine, and midazolam combination for immobilization of captive Nile lechwe antelopes (Kobus magaceros).

Authors:  Pietro Laricchiuta; Valentina De Monte; Marco Campolo; Fabio Grano; Fabrizio Iarussi; Antonio Crovace; Francesco Staffieri
Journal:  J Wildl Dis       Date:  2012-07       Impact factor: 1.535

5.  Chemical immobilisation of wild banteng (Bos javanicus) in northern Australia using detomidine, tiletamine and zolazepam.

Authors:  C J A Bradshaw; L W Traill; K L Wertz; W H White; I M Gurry
Journal:  Aust Vet J       Date:  2005-10       Impact factor: 1.281

6.  Immobilization of muskoxen (Ovibos moschatus) with etorphine and xylazine.

Authors:  Arnoldus Schytte Blix; Hans Lian; John Ness
Journal:  Acta Vet Scand       Date:  2011-06-27       Impact factor: 1.695

7.  [Immobilization of cattle and bison with a combination of xylazine, zolazepam-tiletamine and ketamine].

Authors:  L M Hofkes; M J Hoyer; P van Dijk; P A M Overgaauw
Journal:  Tijdschr Diergeneeskd       Date:  2005-05-01

8.  Detomidine-butorphanol-propofol for carotid artery translocation and castration or ovariectomy in goats.

Authors:  G L Carroll; R N Hooper; M R Slater; S M Hartsfield; N S Matthews
Journal:  Vet Surg       Date:  1998 Jan-Feb       Impact factor: 1.495

9.  To catch a buffalo: field immobilisation of Asian swamp buffalo using etorphine and xylazine.

Authors:  C R McMahon; C J A Bradshaw
Journal:  Aust Vet J       Date:  2008-06       Impact factor: 1.281

10.  Sedative and cardiopulmonary effects of medetomidine hydrochloride and xylazine hydrochloride and their reversal with atipamezole hydrochloride in calves.

Authors:  Eva Rioja; Carolyn L Kerr; Saad S Enouri; Wayne N McDonell
Journal:  Am J Vet Res       Date:  2008-03       Impact factor: 1.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.